We recently published a list of 25 Best Dividend Stocks to Buy According to Billionaires. In this article, we are going to ...

With proper data governance, the pharma industry can improve patient-centricity in trials and bring lifesaving therapies to ...

Although new U.S. tariffs on Canada, Mexico, and China are putting pressure on markets, investors are shifting toward ...

Bristol-Myers Squibb (NYSE:BMY) recently declared a quarterly dividend of $0.62 per share on its common stock, reinforcing ...

The company has asked the U.S. patent office to reconsider patents that could prevent it from selling a new version of its ...

Bristol-Myers Squibb Company (NYSE:BMY) 45th Annual TD Cowen Health Care Conference March 4, 2025 2:30 PM ETCompany ParticipantsAdam Lenkowsky - ...

Bristol Myers Squibb is levering Fulcrum Therapeutics out of its life. | Bristol Myers Squibb is levering Fulcrum ...

Triggers a $20 million research payment to Evotec, enabling further development of a preclinical program in neurodegeneration ...

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will ...

The drug is used to treat Philadelphia chromosome-positive chronic myeloid leukemia (CML) and acute lymphoblastic leukemia ...

Evotec announces key progress in neuroscience collaboration with Bristol Myers Squibb: Hamburg, Germany Wednesday, March 5, 2025, 13:00 Hrs [IST] Evotec SE, a life science company ...